These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 36882732

  • 1. Factors associated with relapse and hospital death in patients coinfected with visceral leishmaniasis and HIV: a longitudinal study.
    Costa LDLN, Lima US, Rodrigues V, Lima MIS, Silva LA, Ithamar J, Azevedo CMPS.
    BMC Infect Dis; 2023 Mar 07; 23(1):141. PubMed ID: 36882732
    [Abstract] [Full Text] [Related]

  • 2. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
    Cota GF, de Sousa MR, de Mendonça AL, Patrocinio A, Assunção LS, de Faria SR, Rabello A.
    PLoS Negl Trop Dis; 2014 Apr 07; 8(4):e2816. PubMed ID: 24743472
    [Abstract] [Full Text] [Related]

  • 3. Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.
    Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD, Lima MA, Mitra G, Kumar D, Pandey K, Van Geertruyden JP, Boelaert M, Burza S.
    Clin Infect Dis; 2015 Oct 15; 61(8):1255-62. PubMed ID: 26129756
    [Abstract] [Full Text] [Related]

  • 4. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M, Palma PP.
    Clin Infect Dis; 2011 Oct 15; 53(7):e91-8. PubMed ID: 21890763
    [Abstract] [Full Text] [Related]

  • 5. Protective Efficacy of Secondary Prophylaxis Against Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients Over the Past 10 Years in Eastern India.
    Goswami RP, Goswami RP, Basu A, Ray Y, Rahman M, Tripathi SK.
    Am J Trop Med Hyg; 2017 Feb 08; 96(2):285-291. PubMed ID: 27879457
    [Abstract] [Full Text] [Related]

  • 6. The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Abongomera C, Diro E, Vogt F, Tsoumanis A, Mekonnen Z, Admassu H, Colebunders R, Mohammed R, Ritmeijer K, van Griensven J.
    Clin Infect Dis; 2017 Oct 30; 65(10):1703-1710. PubMed ID: 29020196
    [Abstract] [Full Text] [Related]

  • 7. Visceral leishmaniasis and HIV coinfection in Latin America.
    Lindoso JA, Cota GF, da Cruz AM, Goto H, Maia-Elkhoury AN, Romero GA, de Sousa-Gomes ML, Santos-Oliveira JR, Rabello A.
    PLoS Negl Trop Dis; 2014 Sep 30; 8(9):e3136. PubMed ID: 25233461
    [Abstract] [Full Text] [Related]

  • 8. Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.
    van Griensven J, Mengesha B, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Vogt F, Adriaensen W, Diro E.
    Front Cell Infect Microbiol; 2018 Sep 30; 8():94. PubMed ID: 29651411
    [Abstract] [Full Text] [Related]

  • 9. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
    Burza S, Mahajan R, Sinha PK, van Griensven J, Pandey K, Lima MA, Sanz MG, Sunyoto T, Kumar S, Mitra G, Kumar R, Verma N, Das P.
    PLoS Negl Trop Dis; 2014 Aug 30; 8(8):e3053. PubMed ID: 25101665
    [Abstract] [Full Text] [Related]

  • 10. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
    Cota GF, de Sousa MR, de Assis TSM, Pinto BF, Rabello A.
    Acta Trop; 2017 Aug 30; 172():186-191. PubMed ID: 28501450
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?
    Leite de Sousa-Gomes M, Romero GAS, Werneck GL.
    PLoS Negl Trop Dis; 2017 Sep 30; 11(9):e0005772. PubMed ID: 28945816
    [Abstract] [Full Text] [Related]

  • 13. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
    Guedes DL, Silva EDD, Castro MCAB, Júnior WLB, Ibarra-Meneses AV, Tsoumanis A, Adriaensen W, van Griensven J, Pereira VRA, Medeiros ZM.
    PLoS Negl Trop Dis; 2022 Jun 30; 16(6):e0010542. PubMed ID: 35714136
    [Abstract] [Full Text] [Related]

  • 14. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia.
    Welay GM, Alene KA, Dachew BA.
    Epidemiol Health; 2016 Jun 30; 39():e2017001. PubMed ID: 28092934
    [Abstract] [Full Text] [Related]

  • 15. New world Leishmania spp. infection in people living with HIV: Concerns about relapses and secondary prophylaxis.
    Araújo CF, Oliveira IBN, Silva MVT, Pereira LIA, Pinto SA, Silveira MB, Dorta ML, Fonseca SG, Gomes RS, Ribeiro-Dias F.
    Acta Trop; 2021 Dec 30; 224():106146. PubMed ID: 34562423
    [Abstract] [Full Text] [Related]

  • 16. Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil.
    Guedes DL, Justo AM, Barbosa Júnior WL, Silva EDD, Aquino SR, Lima Junior MSDC, Montarroyos U, Bezerra GSN, Vieira AVB, Pereira VRA, Medeiros ZM.
    PLoS Negl Trop Dis; 2021 Jan 30; 15(1):e0009067. PubMed ID: 33476331
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?
    Silva de Lima UR, Vanolli L, Moraes EC, Ithamar JS, Azevedo CMPES.
    PLoS One; 2019 Jan 30; 14(12):e0225875. PubMed ID: 31805100
    [Abstract] [Full Text] [Related]

  • 19. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN.
    Clin Infect Dis; 2008 Jun 01; 46(11):1702-9. PubMed ID: 18419422
    [Abstract] [Full Text] [Related]

  • 20. Visceral leishmaniasis and leishmaniasis-HIV coinfection: comparative study.
    Coutinho JVSC, Santos FSD, Ribeiro RDSP, Oliveira IBB, Dantas VB, Santos ABFS, Tauhata JR.
    Rev Soc Bras Med Trop; 2017 Jun 01; 50(5):670-674. PubMed ID: 29160515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.